Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Diansa Gao"'
Autor:
Zhulu Chen, Rui Lan, Tao Ran, Li Tao, Yuxi Zhu, Yanwei Li, Chuan Zhang, Min Mao, Diansa Gao, Zhong Zuo
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study aimed to find the association between four common clinical biomarkers and subsequent ICICT, developing a risk scoring strategy to assess the ICICT risk. Three terminals for ICICT were : Terminal 1, cancer therapy-related cardiomyo
Externí odkaz:
https://doaj.org/article/2a34aefbc29e47d08f40a1dde80f1dba
Publikováno v:
Biomolecules, Vol 12, Iss 12, p 1788 (2022)
Galectin-3 and myeloperoxidase (MPO) are novel biomarkers in the field of cardio-oncology, but conflicting results have been reported. Hence, a meta-analysis was performed to assess the monitoring value of galectin-3 and MPO in cancer-therapy-related
Externí odkaz:
https://doaj.org/article/38cc16adab6542bbaae74533eef5febc
Publikováno v:
Redox Biology, Vol 37, Iss , Pp 101692- (2020)
Objective: Klotho is an aging-suppressor gene which leads to accelerated aging when disrupted. This study was designed to investigate whether glutathione reductase (GR), a critical intracellular antioxidant enzyme, is involved in the pathogenesis of
Externí odkaz:
https://doaj.org/article/af0f4859fba949c78bd267cbebd4d581
Autor:
Xiaoying Zheng, Xuefeng Shan, Weichu Liu, Diansa Gao, Huiming Jiang, Lifen Xue, Lei Hu, Feng Qiu
Publikováno v:
Quality Management in Health Care; Apr-Jun2024, Vol. 33 Issue 2, p86-93, 8p
Publikováno v:
Medicine; 3/22/2024, Vol. 103 Issue 12, p1-9, 9p
Publikováno v:
International Journal of General Medicine. 15:7885-7893
Hong Su,1â 3 Diansa Gao,1 Yanlin Chen,1 Zhong Zuo1 1The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, Peopleâs Republic of China; 2The Chongqing Key Laboratory of Translational Medicine in Major Metabolic Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ad4b8488874537d37f0fd3b8a65896
https://doi.org/10.2147/ijgm.s384119
https://doi.org/10.2147/ijgm.s384119
Amis Sacubitril/Valsartan is now becoming the class one recommendation for HFrEF. Some studies have shown the positive effect of Sacubitril/Valsartan on HFrEF cancer patients, while there is devoid of evidence about the effect of this drug in aged ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86537f92d9b87381137097a448726b78
https://doi.org/10.21203/rs.3.rs-2572497/v1
https://doi.org/10.21203/rs.3.rs-2572497/v1
Publikováno v:
Redox Biology
Redox Biology, Vol 37, Iss, Pp 101692-(2020)
Redox Biology, Vol 37, Iss, Pp 101692-(2020)
Objective Klotho is an aging-suppressor gene which leads to accelerated aging when disrupted. This study was designed to investigate whether glutathione reductase (GR), a critical intracellular antioxidant enzyme, is involved in the pathogenesis of k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051294f282b1184f627d8b6fa78b52f6
http://europepmc.org/articles/PMC7476318
http://europepmc.org/articles/PMC7476318
Publikováno v:
Hypertension. 68:1191-1199
Arterial stiffness is an independent risk factor for stroke and myocardial infarction. This study was designed to investigate the role of SIRT1, an important deacetylase, and its relationship with Klotho, a kidney-derived aging-suppressor protein, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9489dfe4e26fe0699d6ab3267bb826a
https://doi.org/10.1161/hypertensionaha.116.07709
https://doi.org/10.1161/hypertensionaha.116.07709
Publikováno v:
Hypertension (0194911X); Nov2016, Vol. 68 Issue 5, p1191-1199, 9p